PubRank

Adriana Maggi

Author PubWeight™ 55.78‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 In vivo imaging of transcriptionally active estrogen receptors. Nat Med 2002 2.50
2 International Union of Pharmacology. LXIV. Estrogen receptors. Pharmacol Rev 2006 2.15
3 Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice. J Clin Invest 2010 1.90
4 Estrogen receptor-alpha mediates the brain antiinflammatory activity of estradiol. Proc Natl Acad Sci U S A 2003 1.87
5 17beta-estradiol inhibits inflammatory gene expression by controlling NF-kappaB intracellular localization. Mol Cell Biol 2005 1.80
6 Silver paper: the future of health promotion and preventive actions, basic research, and clinical aspects of age-related disease--a report of the European Summit on Age-Related Disease. Aging Clin Exp Res 2009 1.61
7 Requirement of estrogen receptor-alpha in insulin-like growth factor-1 (IGF-1)-induced uterine responses and in vivo evidence for IGF-1/estrogen receptor cross-talk. J Biol Chem 2001 1.60
8 A lack of ovarian function increases neuroinflammation in aged mice. Endocrinology 2012 1.53
9 Regulation of postnatal lung development and homeostasis by estrogen receptor beta. Mol Cell Biol 2003 1.44
10 Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases. Front Neuroendocrinol 2008 1.23
11 The androgen derivative 5alpha-androstane-3beta,17beta-diol inhibits prostate cancer cell migration through activation of the estrogen receptor beta subtype. Cancer Res 2005 1.19
12 Haploinsufficiency of the corepressor of estrogen receptor activity (REA) enhances estrogen receptor function in the mammary gland. Proc Natl Acad Sci U S A 2006 1.17
13 The endogenous estrogen status regulates microglia reactivity in animal models of neuroinflammation. Endocrinology 2006 1.13
14 A novel peroxisome proliferator-activated receptor responsive element-luciferase reporter mouse reveals gender specificity of peroxisome proliferator-activated receptor activity in liver. Mol Endocrinol 2006 1.10
15 Amino acid-dependent activation of liver estrogen receptor alpha integrates metabolic and reproductive functions via IGF-1. Cell Metab 2011 1.10
16 Estrogen action in neuroprotection and brain inflammation. Ann N Y Acad Sci 2006 0.99
17 Estrogen receptor beta and the progression of prostate cancer: role of 5alpha-androstane-3beta,17beta-diol. Endocr Relat Cancer 2010 0.98
18 HDACs class II-selective inhibition alters nuclear receptor-dependent differentiation. J Mol Endocrinol 2010 0.98
19 Regulation of the lipopolysaccharide signal transduction pathway by 17beta-estradiol in macrophage cells. J Steroid Biochem Mol Biol 2004 0.98
20 In vivo imaging reveals selective peroxisome proliferator activated receptor modulator activity of the synthetic ligand 3-(1-(4-chlorobenzyl)-3-t-butylthio-5-isopropylindol-2-yl)-2,2-dimethylpropanoic acid (MK-886). Mol Pharmacol 2008 0.95
21 Suppurative adenitis of preputial glands associated with Corynebacterium mastitidis infection in mice. J Am Assoc Lab Anim Sci 2010 0.92
22 Tissue specificity of 8-prenylnaringenin: protection from ovariectomy induced bone loss with minimal trophic effects on the uterus. J Steroid Biochem Mol Biol 2005 0.91
23 Estrogen receptor-alpha as a drug target candidate for preventing lung inflammation. Endocrinology 2009 0.89
24 Transgenic animal models in toxicology: historical perspectives and future outlook. Toxicol Sci 2011 0.88
25 Inducible nitric oxide synthase mediates bone loss in ovariectomized mice. Endocrinology 2003 0.86
26 Tetradian oscillation of estrogen receptor α is necessary to prevent liver lipid deposition. Proc Natl Acad Sci U S A 2012 0.86
27 Molecular imaging of nuclear factor-Y transcriptional activity maps proliferation sites in live animals. Mol Biol Cell 2012 0.86
28 Selective agonists of estrogen receptor isoforms: new perspectives for cardiovascular disease. Arterioscler Thromb Vasc Biol 2006 0.86
29 Estrogenic activities in rodent estrogen-free diets. Endocrinology 2005 0.85
30 Estrogen receptor antagonist fulvestrant (ICI 182,780) inhibits the anti-inflammatory effect of glucocorticoids. Mol Pharmacol 2006 0.85
31 Alternative activation of human macrophages is rescued by estrogen treatment in vitro and impaired by menopausal status. J Clin Endocrinol Metab 2015 0.85
32 An innovative method to classify SERMs based on the dynamics of estrogen receptor transcriptional activity in living animals. Mol Endocrinol 2010 0.85
33 The peroxisome proliferator-activated receptor γ (PPARγ) controls natural protective mechanisms against lipid peroxidation in amyotrophic lateral sclerosis. J Biol Chem 2012 0.84
34 Genistein is an efficient estrogen in the whole-body throughout mouse development. Toxicol Sci 2008 0.83
35 Identification of xenoestrogens in food additives by an integrated in silico and in vitro approach. Chem Res Toxicol 2009 0.82
36 Molecular imaging provides novel insights on estrogen receptor activity in mouse brain. Mol Imaging 2009 0.82
37 Estrogen receptor-mediated signalling in female mice is locally activated in response to wounding. Mol Cell Endocrinol 2013 0.81
38 Novel insights on imaging sex-hormone-dependent tumourigenesis in vivo. Endocr Relat Cancer 2011 0.81
39 European silver paper on the future of health promotion and preventive actions, basic research and clinical aspects of age-related disease. Endokrynol Pol 2009 0.81
40 Looking at nuclear receptors from the heights of Erice. Workshop on nuclear receptor structure and function. EMBO Rep 2002 0.81
41 Development of a bicistronic vector for multimodality imaging of estrogen receptor activity in a breast cancer model: preliminary application. Eur J Nucl Med Mol Imaging 2007 0.81
42 The conundrum of estrogen receptor oscillatory activity in the search for an appropriate hormone replacement therapy. Endocrinology 2011 0.81
43 Estrogen receptor alpha, a molecular switch converting transforming growth factor-alpha-mediated proliferation into differentiation in neuroblastoma cells. J Biol Chem 2003 0.81
44 Molecular imaging of cytochrome P450 activity in mice. Pharmacol Res 2012 0.80
45 Cancer modeling: modern imaging applications in the generation of novel animal model systems to study cancer progression and therapy. Int J Biochem Cell Biol 2007 0.79
46 Distinct roles of estrogen receptor-alpha and beta in the modulation of vascular inducible nitric-oxide synthase in diabetes. J Pharmacol Exp Ther 2008 0.79
47 Profiling of drug action using reporter mice and molecular imaging. Methods Mol Biol 2010 0.79
48 Effects of Crude Oil/Dispersant Mixture and Dispersant Components on PPARγ Activity in Vitro and in Vivo: Identification of Dioctyl Sodium Sulfosuccinate (DOSS; CAS #577-11-7) as a Probable Obesogen. Environ Health Perspect 2015 0.78
49 Novel locally active estrogens accelerate cutaneous wound healing. A preliminary study. Mol Pharm 2009 0.78
50 Estrogen-like effects of diet-derived cadmium differ from those of orally administered CdCl(2) in the ERE-luc estrogen reporter mouse model. Toxicol Lett 2010 0.77
51 Genistein accumulates in body depots and is mobilized during fasting, reaching estrogenic levels in serum that counter the hormonal actions of estradiol and organochlorines. Toxicol Sci 2007 0.77
52 Differential effect of pure isoflavones and soymilk on estrogen receptor activity in mice. Toxicol Appl Pharmacol 2009 0.76
53 Molecular imaging, an innovative methodology for whole-body profiling of endocrine disrupter action. Toxicol Sci 2008 0.76
54 LT175 is a novel PPARα/γ ligand with potent insulin-sensitizing effects and reduced adipogenic properties. J Biol Chem 2014 0.75
55 Reporter mice for the study of long-term effects of drugs and toxic compounds. Methods Mol Biol 2014 0.75
56 Global profiling of TSEC proliferative potential by the use of a reporter mouse for proliferation. Reprod Sci 2012 0.75
57 [European Silver Paper. European document on the future of health promotion and preventive measures, basic research and clinical aspects of aging-related diseases]. Rev Esp Geriatr Gerontol 2009 0.75
58 Estrogen Receptor-α as a Drug Target Candidate for Preventing Lung Inflammation. Endocr Rev 2009 0.75